Regenerative Medical Technology Group Inc. Cash and Restricted Cash
Regenerative Medical Technology Group Inc. (RMTG) had Cash and Restricted Cash of $1.32 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-19
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.32M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.06M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $956.72K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.19M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $1.32M 10-Q · filed 2026-08-19 |
| 2026-03-31 | $1.06M 10-Q · filed 2026-06-09 |
| 2025-12-31 | $956.72K 10-Q · filed 2026-08-19 |
| 2025-09-30 | $1.19M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $1.61M 10-Q · filed 2026-08-19 |
| 2025-03-31 | $1.22M 10-Q · filed 2026-06-09 |
| 2024-12-31 | $1.17M 10-Q · filed 2026-08-19 |
| 2024-09-30 | $836.43K 10-Q · filed 2025-11-19 |
| 2024-06-30 | $617.09K 10-Q · filed 2025-08-19 |
| 2024-03-31 | $579.35K 10-Q · filed 2025-05-20 |
| 2023-12-31 | $530.54K 10-K · filed 2026-05-14 |
| 2023-09-30 | $1.14M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $1.23M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $1.64M 10-Q · filed 2024-05-20 |
| 2022-12-31 | $1.65M 10-K · filed 2025-04-15 |
| 2022-09-30 | $1.77M 10-Q · filed 2023-11-20 |
| 2022-06-30 | $1.92M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $2.46M 10-Q · filed 2023-05-22 |
| 2021-12-31 | $2.98M 10-K · filed 2024-04-15 |
| 2021-09-30 | $10.73M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $10.49M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $787.67K 10-Q · filed 2022-05-19 |
| 2020-12-31 | $42.53K 10-K · filed 2023-04-14 |
| 2020-06-30 | $11.57K 10-Q · filed 2021-02-08 |
| 2019-12-31 | $23.38K 10-K · filed 2022-05-05 |
| 2019-06-30 | $40.15K 10-Q · filed 2021-02-08 |
| 2018-12-31 | $30.83K 10-Q · filed 2021-02-08 |